National Stock Number
6550-00-947-2911
National Stock Number (NSN) 6550-00-947-2911, or NIIN 009472911, (antigen) was assigned March 25, 1966 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There are 3 manufacturer part numbers associated with this NSN. 2 of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 3 suppliers. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, there are no suppliers that are deemed design controlled or valid supply parts. ISO Group has several sources of supply for this NSN.
This part number has not been procured by the US Government in over 5 years.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 01, 2020, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 24507. [A DIAGNOSTIC REAGENT FOR SYPHILIS IN SERUM AND SPINAL FLUID. A SAMPLE OF EACH LOT IS TESTED FOR STANDARD REACTIVITY BY VENERAL DISEASE RESEARCH LABORATORY, UNITED STATES PUBLIC HEALTH SERVICE.]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6550009472911 does not contain precious metals.
This NSN is associated to Schedule B 3004901000: medicaments containing antigens or hyaluronic acid or its sodium salt. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325412: pharmaceutical preparation manufacturing.
This information was last updated on Jul 01, 2025.